Horan Capital Advisors, Llc. Abb Vie Inc. Transaction History

Horan Capital Advisors, Llc.

$298 Million
Q3 2024

A detailed history of Horan Capital Advisors, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Horan Capital Advisors, Llc. holds 17,756 shares of ABBV stock, worth $3.27 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

17,756

Previous 17,941 1.03%

Holding current value

$3.27 Million

Previous $3.08 Million 13.94%

% of portfolio

1.18%

Previous 1.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$163.84 - $199.33 $30,310 - $36,876	-185 Reduced 1.03%	17,756 $3.51 Million
Q2 2024 Aug 06, 2024	SELL	$154.79 - $180.76 $3,560 - $4,157	-23 Reduced 0.13%	17,941 $3.08 Million
Q1 2024 May 01, 2024	BUY	$159.82 - $182.1 $13,744 - $15,660	86 Added 0.48%	17,964 $3.27 Million
Q4 2023 Feb 06, 2024	BUY	$137.6 - $154.97 $16,236 - $18,286	118 Added 0.66%	17,878 $2.77 Million
Q3 2023 Nov 01, 2023	SELL	$133.59 - $154.65 $67,462 - $78,098	-505 Reduced 2.76%	17,760 $2.65 Million
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $16,033 - $19,952	121 Added 0.67%	18,265 $2.46 Million
Q1 2023 May 01, 2023	BUY	$144.61 - $166.54 $31,091 - $35,806	215 Added 1.2%	18,144 $2.89 Million
Q4 2022 Feb 07, 2023	SELL	$138.31 - $165.87 $35,269 - $42,296	-255 Reduced 1.4%	17,929 $2.9 Million
Q3 2022 Nov 01, 2022	BUY	$134.21 - $153.93 $51,402 - $58,955	383 Added 2.15%	18,184 $2.44 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $877,465 - $1.12 Million	-6,376 Reduced 26.37%	17,801 $2.73 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $18,213 - $22,597	138 Added 0.57%	24,177 $3.92 Million
Q4 2021 Feb 01, 2022	SELL	$107.43 - $135.93 $103,777 - $131,308	-966 Reduced 3.86%	24,039 $3.26 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $65,116 - $73,917	612 Added 2.51%	25,005 $2.7 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $74,383 - $82,867	707 Added 2.98%	24,393 $2.75 Million
Q1 2021 May 05, 2021	BUY	$102.3 - $112.62 $44,500 - $48,989	435 Added 1.87%	23,686 $2.56 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $81,133 - $109,539	1,008 Added 4.53%	23,251 $2.49 Million
Q3 2020 Nov 04, 2020	BUY	$85.91 - $100.83 $34,707 - $40,735	404 Added 1.85%	22,243 $1.95 Million
Q2 2020 Aug 03, 2020	SELL	$73.37 - $98.18 $20,910 - $27,981	-285 Reduced 1.29%	21,839 $2.14 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $23,349 - $35,399	362 Added 1.66%	22,124 $1.69 Million
Q4 2019 Feb 05, 2020	SELL	$72.13 - $90.25 $44,359 - $55,503	-615 Reduced 2.75%	21,762 $1.93 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $3,149 - $3,786	50 Added 0.22%	22,377 $1.69 Million
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $16,753 - $21,414	255 Added 1.16%	22,327 $1.62 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $168,550 - $198,376	-2,185 Reduced 9.01%	22,072 $1.78 Million
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $20,630 - $25,442	-265 Reduced 1.08%	24,257 $2.24 Million
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $53,346 - $59,304	-600 Reduced 2.39%	24,522 $2.32 Million
Q2 2018 Sep 13, 2018	BUY	$89.78 - $106.23 $2.25 Million - $2.66 Million	25,072 Added 50144.0%	25,122 $2.33 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $2.74 Million - $3.24 Million	-30,541 Reduced 99.84%	50 $5,000
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $3.32 Million - $4.45 Million	-36,126 Reduced 54.15%	30,591 $2.9 Million
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $2.43 Million - $2.66 Million	27,087 Added 68.35%	66,717 $8.55 Million
Q3 2017 Nov 08, 2017	BUY	$69.85 - $89.22 $2.77 Million - $3.54 Million	39,630	39,630 $3.52 Million

Others Institutions Holding ABBV

# of Institutions

3,886

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Capital Advisors, Llc. with notifications on news.

Account

Horan Capital Advisors, Llc. Abb Vie Inc. Transaction History